EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs

Jessica R Box, Mark A Oyama iD, Ariel S Mosenco, Rebecka S Hess iD

Journal of Veterinary Internal Medicine · 01.05.2024 · 38 (3) · 1353-1358

DOI: 10.1111/jvim.17053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.05.2024. Verfasst von Jessica R Box und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Canagliflozin, Dog Diseases, Glucose, Insulin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The utility of sodium-glucose cotransporter 2 inhibitors (SGLT2i) has not been reported in insulin-treated diabetic dogs. Hypothesis Canagliflozin, a PO-administered SGLT2i, decreases interstitial glucose concentration (IG) in insulin-treated diabetic dogs. Animals Five insulin-treated diabetic dogs.

Methods

Uncontrolled open label longitudinal study. Canagliflozin (2-4 mg/kg/day PO) was added to an unchanged insulin dose for 7 days. Fractional excretion of glucose was calculated by dividing the product of urine glucose and serum creatinine concentrations by the product of serum glucose and urine creatinine concentrations. Hypoglycemia was defined as IG <60 mg/dL.

Results

Median IG in 2869 measurements obtained while dogs were treated with insulin and canagliflozin was 87 mg/dL (range, 40-500 mg/dL) and was significantly lower than median IG in 1426 measurements obtained while dogs were treated with insulin alone (212 mg/dL; range, 41-500 mg/dL; P < .001). Median fractional excretion of glucose when dogs were treated with insulin and canagliflozin was 1.1% (range, 0.9%-2.0%), significantly higher than when dogs were treated with insulin alone (0.3%; range, 0.01%-1.0%; P = .04). The frequency of hypoglycemia was higher in dogs treated with insulin and canagliflozin (544 of 2869 IG measurements, 19%) compared with the frequency of hypoglycemia in dogs treated with insulin alone (52 of 1426 IG measurements, 4%; P < .001). Conclusions and Clinical Importance Canagliflozin may have a role in improving glycemic control in insulin-treated diabetic dogs, but the dose of insulin should be decreased when adding canagliflozin to insulin treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CanagliflozinDog DiseasesGlucoseInsulinSodium-Glucose Transporter 2 InhibitorsAnimalsDogsFemaleMaleBlood GlucoseDiabetes MellitusHypoglycemiaHypoglycemic AgentsLongitudinal Studies

Stichwörter der Autor:innen

caninediabetes mellitusdiabetic ketoacidosisfractional excretionglycemic controlhypoglycemia

Substanzen

Blood GlucoseCanagliflozinGlucoseHypoglycemic AgentsInsulinSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Mark A Oyama, Rebecka S Hess

Zitieren

APA

Box, J. R., Oyama, M. A., Mosenco, A. S., & Hess, R. S. (2024). Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs. Journal of Veterinary Internal Medicine, 38(3), 1353-1358. https://doi.org/10.1111/jvim.17053

Vancouver

Box JR, Oyama MA, Mosenco AS, Hess RS. Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs. Journal of Veterinary Internal Medicine. 2024;38(3):1353-1358. doi:10.1111/jvim.17053

BibTeX
@article{Box2024,
  author = {Box, Jessica R and Oyama, Mark A and Mosenco, Ariel S and Hess, Rebecka S},
  title = {Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {3},
  pages = {1353--1358},
  doi = {10.1111/jvim.17053}
}
Kostenlos starten →